CLINICAL_TRIALS
trial_result
· 2022-02-01
Clinical Trial Update: A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis [Phase 2]
Summary
Phase 2 trial evaluating ACT-774312 in bilateral nasal polyposis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Bilateral Nasal Polyposis | Phase 2 | Status: COMPLETED | Results posted: 2022-02-01